S. P. L. Travis
John Radcliffe Hospital
Oxford OX3 9DU
UK
Name/email consistency: high
- European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Travis, S.P., Stange, E.F., Lémann, M., Oresland, T., Chowers, Y., Forbes, A., D'Haens, G., Kitis, G., Cortot, A., Prantera, C., Marteau, P., Colombel, J.F., Gionchetti, P., Bouhnik, Y., Tiret, E., Kroesen, J., Starlinger, M., Mortensen, N.J. Gut (2006)
- New thinking: theory vs practice. A case study illustrating evidence-based therapeutic decision making. Travis, S.P. Colorectal. Dis (2006)
- Review article: saving the colon in severe colitis - the case for medical therapy. Travis, S. Aliment. Pharmacol. Ther. (2006)
- Dose escalation of 5ASA: does it work?. Travis, S.P. Dig. Liver. Dis (2005)
- RDP58 is a novel and potentially effective oral therapy for ulcerative colitis. Travis, S., Yap, L.M., Hawkey, C., Warren, B., Lazarov, M., Fong, T., Tesi, R.J. Inflamm. Bowel Dis. (2005)
- Advances in therapeutic approaches to ulcerative colitis and Crohn's disease. Travis, S. Curr. Gastroenterol. Rep (2005)
- What is the optimal dosage of mesalazine to maintain remission in patients with ulcerative colitis?. Travis, S. Nature Clinical Practice. Gastroenterology & Hepatology (2005)
- Predicting outcome in severe ulcerative colitis. Travis, S.P. Dig. Liver. Dis (2004)
- Review article: the management of mild to severe acute ulcerative colitis. Travis, S.P. Aliment. Pharmacol. Ther. (2004)
- Recent advances in immunomodulation in the treatment of inflammatory bowel disease. Travis, S. Eur. J. Gastroenterol. Hepatol (2003)
- Which 5-ASA?. Travis, S.P. Gut (2002)
- Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody. Travis, S.P., Czajkowski, M., McGovern, D.P., Watson, R.G., Bell, A.L. Gut (2001)
- Azathioprine for prevention of postoperative recurrence in Crohn's disease. Travis, S. Eur. J. Gastroenterol. Hepatol (2001)